期刊文献+

青黛颗粒对溃疡性结肠炎大鼠结肠黏膜MUC2和iNOS基因表达的影响 被引量:15

Qingdai Granules up-regulate MUC2 mRNA expression but down-regulate iNOS mRNA expression in the colonic mucosa of rats with ulcerative colitis
暂未订购
导出
摘要 目的:观察青黛颗粒对TNBS诱导的溃疡性结肠炎(UC)大鼠结肠黏膜黏蛋白(MUC2)及诱导型一氧化氮合成酶(iNOS)基因表达的影响,探讨其治疗UC的可能作用机制.方法:将54只SD实验大鼠随机分为正常对照组、模型对照组、阳性药物治疗组(SASP,500mg/kg)、青黛颗粒600、900、1200mg/kg治疗组.造模后第3天开始灌胃给药,共给药10d.实验第14天,处死大鼠,剖取其病变结肠组织,比较各组大鼠的DAI积分和CMDI评分,用逆转录聚合酶链反应(RT-PCR)法检测MUC2及iNOS基因的表达.结果:较模型组青黛颗粒900、1200mg/kg治疗组能显著降低实验大鼠DAI积分和CMDI评分,上调结肠组织中MUC2的基因表达(2.06±0.70vs1.24±0.47;2.34±0.86vs1.24±0.47,均P<0.01),且青黛颗粒1200mg/kg治疗组能下调iNOS的基因表达(0.35±0.12vs0.62±0.31,P<0.05).结论:青黛颗粒可能通过上调结肠黏膜MUC2的基因表达并下调iNOS的基因表达而起到抗TNBS诱导的大鼠溃疡性结肠炎的作用. AIM: To investigate the effects of Qingdai Granules (QDG) on the expression of mucin 2 (MUC2) and inducible nitric oxide synthase (iNOS) mRNAs in the colonic mucosa of rats with ulcerative colitis. METHODS: Ulcerative colitis was induced in rats by giving an enema of trinitrobenzene sulphonic acid (TNBS) and ethanol. The experimental animals were randomly divided into six groups: normal group, model group, sulfasalazine (SASP) group (500 mg/kg), and low-,medium- and high-dose QDG groups (600, 900 and 1 200 mg/kg). Except the normal group, the other groups were given intragastrically normal saline, SASP, and different concentrations of QDG, respectively, from day 3 after model establishment for 10 d. On day 14, rats were killed to evaluate disease activity index (DAI) and colon mucosa damage index (CMDI). The expression of MUC2 and iNOS mRNAs in the colonic mucosa of rats was detected by reverse transcription-polymerase chain reaction (RTPCR). RESULTS: Compared with the model group, the DAI and CMDI in the medium- and high-dose QDG groups significantly decreased, the expression of MUC2 mRNA in the colon of rats in the medium- and high-dose QDG groups was significantly up-regulated (2.06 ± 0.70 vs 1.24 ± 0.47 and 2.34 ± 0.86 vs 1.24 ± 0.47; both P 0.01), and the expression of iNOS mRNA in the high-dose QDG group was significantly down-regulated (0.35 ± 0.12 vs 0.62 ± 0.31, P 0.05). CONCLUSION: QDG can exert protective effects against rat ulcerative colitis perhaps by upregulating MUC2 mRNA expression and down-regulating iNOS mRNA expression.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第9期937-941,共5页 World Chinese Journal of Digestology
基金 辽宁省自然科学基金资助项目 No.20092130~~
关键词 溃疡性结肠炎 青黛颗粒 MUC2 诱导型一氧化氮合成酶 Ulcerative colitis Qingdai Granules Mucin 2 Inducible nitric oxide synthase
  • 相关文献

参考文献21

  • 1Loftus EV Jr.Clinical epidemiology of inflammatory bowel disease:Incidence,prevalence,and environmental influences.Gastroenterology 2004;126:1504-1517.
  • 2Newman B,Siminovitch KA.Recent advances in the genetics of inflammatory bowel disease.Curr Opin Gastroentero12005; 21:401-407.
  • 3Schreiber S,Rosenstiel P,Albrecht M,Hampe J,Krawczak M.Genetics of Crohn disease,an archetypal inflammatory barrier disease.Nat Rev Genet 2005; 6:376-388.
  • 4Sartor RB.Microbial influences in inflammatory bowel disease:role in pathogenesis and clinical implications.In:Eds Sartor RB and Sandborn WJ.Kirsner's Inflammatory Bowel Diseases.Philadelphia:Elsevier,2004:138-162.
  • 5Mow WS,Vasiliauskas EA,Lin YC,Fleshner PR,Papadakis KA,Taylor KD,Landers CJ,Abreu-Martin MT,Rotter JI,Yang H,Targan SR.Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.Gastroenterology 2004; 126:414-424.
  • 6Sartor RB,Hoentjen F.Proinflammatory cytokines and signaling pathways in intesUnal innate immune cells,in Mucosal Immunology,J.Mestecky,M.E.Lamm,J.R.McGhee,J.Bienenstock,L.Mayer,and W.Strober,Editors.2005,Elsevier Academic Press:London,681-701.
  • 7杜立阳,邹莉菠,宗士群,刘悦.青黛颗粒抗氧化作用的实验研究[J].中国中西医结合消化杂志,2003,11(3):144-145. 被引量:13
  • 8邹莉波,刘艳,先宇飞,吴琦,杨新爱,杜立阳.复方青黛颗粒治疗溃疡性结肠炎的机制[J].沈阳药科大学学报,2006,23(2):119-122. 被引量:13
  • 9Morris GP,Beck PL,Herridge MS,Depew WT,Szewczuk MR,Wallace JL.Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology 1989; 96:795-803.
  • 10Millar AD,Rampton DS,Chander CL,Claxson AW,Blades S,Coumbe A,Panetta J,Morris CJ,Blake DR.Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.Gut 1996; 39:407-415.

二级参考文献12

共引文献28

同被引文献186

引证文献15

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部